The M1 muscarinic acetylcholine receptor (M1-receptor) plays a crucial role in learning and memory and is a validated drug target for the treatment of Alzheimer’s disease (AD). This evidence concerns the gene CHRM1 and early-onset autosomal dominant Alzheimer disease.